Market Update

Shares of Immucor Inc

surged about 30.2% after the company agreed to be bought by TPG Capital in a deal worth $1.97 billion or $27 per share in cash. The price represents a 30% premium over BLUD's closing share price on July 1. The transaction is likely to close in the second half of this year. The deal was unanimously approved by the Immucor board of directors. Shares of Oncolytics Biotech Inc

gained about 3.1% after the company appointed George M. Gill, MD as its Chief Medical Officer. Dr. Gill has been Senior Vice President of Clinical Safety and Regulatory Affairs and an officer of Oncolytics since 2002. Shares of Worthington Industries Inc

fell about 0.5% after the company purchased BernzOmatic from Irwin Industrial Tool Company, a subsidiary of Newell Rubbermaid Inc

. The terms of the transaction were not disclosed. The transaction was financed with the company's revolving credit facility.